Company Profiles

driven by the PitchBook Platform

Acetylon Pharmaceuticals

Description

Developer of small-molecule drugs. The company is developing next-generation selective small molecule histone deacetylase (HDAC) inhibitors, which allow for epigenetic regulation of gene and protein function for the treatment of patients with critical unmet medical needs.

2008

Founded

M&A

Status

11-50

Employees

M&A

Latest Deal Type

$200M

Latest Deal Amount

$153M

Total Amount Raised

Description

Developer of small-molecule drugs. The company is developing next-generation selective small molecule histone deacetylase (HDAC) inhibitors, which allow for epigenetic regulation of gene and protein function for the treatment of patients with critical unmet medical needs.

Website:

www.acetylon.com

Ownership Status

Acquired/Merged

Financing Status

Formerly VC-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

Seaport Center, 70 Fargo Street Suite 205 Boston, MA 02210United States +1 (617) 245-1300
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Acetylon Pharmaceuticals's full profile, request a free trial.

Acetylon Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Acetylon Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Acetylon Pharmaceuticals Executive Team (16)

NameTitleBoard
Seat
Contact
Info
Min YangDirector, Biomarker Development
Faye SeyediDirector, Drug Substance Manufacturing
Ken JacobsDirector, Program Management
Kailash Bhol Ph.DSenior Director, Preclinical Development
Denise HayesSenior Director, Regulatory Affairs
Min Yang Director, Biomarker Development
Faye Seyedi Director, Drug Substance Manufacturing
Ken Jacobs Director, Program Management
Kailash Bhol Ph.D Senior Director, Preclinical Development
Denise Hayes Senior Director, Regulatory Affairs

Acetylon Pharmaceuticals Board Members (7)

NameRepresentingRoleSinceContact
Info
Bruce Downey JDSelfBoard Member000 0000
Elena Prokupets Ph.DSelfBoard Member000 0000
James Bradner MDAcetylon PharmaceuticalsScientific Founder & Board Member000 0000
Kenneth Anderson MDAcetylon PharmaceuticalsScientific Founder & Board Member000 0000
Marc CohenAcetylon PharmaceuticalsCo-Founder & Chairman000 0000
Bruce Downey JD Board Member Self
Elena Prokupets Ph.D Board Member Self
James Bradner MD Scientific Founder & Board Member Acetylon Pharmaceuticals
Kenneth Anderson MD Scientific Founder & Board Member Acetylon Pharmaceuticals
Marc Cohen Co-Founder & Chairman Acetylon Pharmaceuticals
Request full access to PitchBook